You are about to leave the Clinical Value website now.

Cancel

A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort

You May Also Like

13 September 2024

Empowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour board meetings and patient care management

Read More
19 August 2024

Pioneering Innovations in HCC Detection for Enhance Patient Outcomes – Chang Gung Memorial Hospital

Read More
19 August 2024

Strategic Efficiencies: Evaluating Cost-Effectiveness of Biomarker-Based HCC Surveillance

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.